| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.30e-05 | 51 | 119 | 5 | GO:0140303 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.20e-05 | 28 | 119 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 8.02e-05 | 74 | 119 | 5 | GO:0005548 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 1.05e-04 | 3 | 119 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | floppase activity | 1.09e-04 | 16 | 119 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 2.10e-04 | 4 | 119 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | alanine-tRNA ligase activity | 2.10e-04 | 4 | 119 | 2 | GO:0004813 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 2.18e-04 | 20 | 119 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 7.25e-04 | 7 | 119 | 2 | GO:0090555 | |
| GeneOntologyMolecularFunction | clathrin light chain binding | 7.25e-04 | 7 | 119 | 2 | GO:0032051 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 9.63e-04 | 8 | 119 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.15e-03 | 196 | 119 | 6 | GO:0005319 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 PTPRM ROBO1 PLXNB3 | 8.00e-10 | 187 | 118 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 COLEC10 ITGB2 PTPRM ROBO1 PLXNB3 | 3.25e-09 | 313 | 118 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | phospholipid translocation | 7.11e-07 | 55 | 118 | 6 | GO:0045332 | |
| GeneOntologyBiologicalProcess | lipid translocation | 1.20e-06 | 60 | 118 | 6 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 1.93e-06 | 65 | 118 | 6 | GO:0097035 | |
| GeneOntologyBiologicalProcess | phospholipid transport | 2.56e-06 | 106 | 118 | 7 | GO:0015914 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PCDHA13 PCDHA12 PELI1 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 COLEC10 ITGB2 PTPRM SMARCC1 ROBO1 CTNND1 TNXB PLXNB3 | 4.00e-05 | 1077 | 118 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 4.11e-05 | 162 | 118 | 7 | GO:0015748 | |
| GeneOntologyBiologicalProcess | fumarate metabolic process | 9.70e-05 | 3 | 118 | 2 | GO:0006106 | |
| GeneOntologyBiologicalProcess | ceramide translocation | 9.70e-05 | 3 | 118 | 2 | GO:0099040 | |
| GeneOntologyBiologicalProcess | alanyl-tRNA aminoacylation | 1.93e-04 | 4 | 118 | 2 | GO:0006419 | |
| Domain | Cadherin_tail | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.26e-12 | 37 | 118 | 9 | PF15974 |
| Domain | Cadherin_CBD | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.26e-12 | 37 | 118 | 9 | IPR031904 |
| Domain | Cadherin_2 | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.80e-10 | 65 | 118 | 9 | PF08266 |
| Domain | Cadherin_N | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.80e-10 | 65 | 118 | 9 | IPR013164 |
| Domain | Cadherin_CS | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.96e-08 | 109 | 118 | 9 | IPR020894 |
| Domain | CADHERIN_1 | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.06e-08 | 113 | 118 | 9 | PS00232 |
| Domain | Cadherin | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.06e-08 | 113 | 118 | 9 | PF00028 |
| Domain | CADHERIN_2 | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.38e-08 | 114 | 118 | 9 | PS50268 |
| Domain | - | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.38e-08 | 114 | 118 | 9 | 2.60.40.60 |
| Domain | CA | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.73e-08 | 115 | 118 | 9 | SM00112 |
| Domain | Cadherin-like | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.10e-08 | 116 | 118 | 9 | IPR015919 |
| Domain | Cadherin | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 5.92e-08 | 118 | 118 | 9 | IPR002126 |
| Domain | - | 6.68e-06 | 207 | 118 | 9 | 1.25.40.10 | |
| Domain | TPR-like_helical_dom | 1.72e-05 | 233 | 118 | 9 | IPR011990 | |
| Domain | Clathrin_H-chain_propeller_rpt | 3.96e-05 | 2 | 118 | 2 | IPR022365 | |
| Domain | Clathrin-link | 3.96e-05 | 2 | 118 | 2 | PF09268 | |
| Domain | - | 3.96e-05 | 2 | 118 | 2 | 2.130.10.110 | |
| Domain | Clathrin_heavy_chain | 3.96e-05 | 2 | 118 | 2 | IPR016341 | |
| Domain | Ala_tRNA_ligase_euk/bac | 3.96e-05 | 2 | 118 | 2 | IPR023033 | |
| Domain | Clathrin_H-chain_propeller_N | 3.96e-05 | 2 | 118 | 2 | IPR001473 | |
| Domain | Ala-tRNA-ligase_IIc_anticod-bd | 3.96e-05 | 2 | 118 | 2 | IPR018162 | |
| Domain | Clathrin_H-chain_link/propller | 3.96e-05 | 2 | 118 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 3.96e-05 | 2 | 118 | 2 | PF01394 | |
| Domain | Clathrin_H-chain_linker_core | 3.96e-05 | 2 | 118 | 2 | IPR015348 | |
| Domain | Ala-tRNA-lgiase_IIc | 1.18e-04 | 3 | 118 | 2 | IPR002318 | |
| Domain | Clathrin_H-chain_linker | 1.18e-04 | 3 | 118 | 2 | IPR012331 | |
| Domain | RPAP3-like_C | 1.18e-04 | 3 | 118 | 2 | IPR025986 | |
| Domain | RPAP3_C | 1.18e-04 | 3 | 118 | 2 | PF13877 | |
| Domain | CLH | 1.18e-04 | 3 | 118 | 2 | SM00299 | |
| Domain | Ala-tRNA-synth_IIc_core | 2.36e-04 | 4 | 118 | 2 | IPR018165 | |
| Domain | Ala-tRNA-synth_IIc_N | 2.36e-04 | 4 | 118 | 2 | IPR018164 | |
| Domain | tRNA-synt_2c | 2.36e-04 | 4 | 118 | 2 | PF01411 | |
| Domain | AA_TRNA_LIGASE_II_ALA | 2.36e-04 | 4 | 118 | 2 | PS50860 | |
| Domain | Clathrin | 8.14e-04 | 7 | 118 | 2 | PF00637 | |
| Domain | tRNA_SAD | 8.14e-04 | 7 | 118 | 2 | IPR012947 | |
| Domain | tRNA_SAD | 8.14e-04 | 7 | 118 | 2 | SM00863 | |
| Domain | CHCR | 8.14e-04 | 7 | 118 | 2 | PS50236 | |
| Domain | tRNA_SAD | 8.14e-04 | 7 | 118 | 2 | PF07973 | |
| Domain | Clathrin_H-chain/VPS_repeat | 1.08e-03 | 8 | 118 | 2 | IPR000547 | |
| Domain | Thr/Ala-tRNA-synth_IIc_edit | 1.08e-03 | 8 | 118 | 2 | IPR018163 | |
| Domain | Tyr_Pase_AS | 1.18e-03 | 73 | 118 | 4 | IPR016130 | |
| Domain | TPR | 1.36e-03 | 129 | 118 | 5 | SM00028 | |
| Domain | Copine | 1.38e-03 | 9 | 118 | 2 | PF07002 | |
| Domain | Cl-channel_core | 1.38e-03 | 9 | 118 | 2 | IPR014743 | |
| Domain | - | 1.38e-03 | 9 | 118 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.38e-03 | 9 | 118 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.38e-03 | 9 | 118 | 2 | IPR001807 | |
| Domain | Copine | 1.38e-03 | 9 | 118 | 2 | IPR010734 | |
| Domain | TPR_repeat | 1.56e-03 | 133 | 118 | 5 | IPR019734 | |
| Domain | TPR_7 | 1.72e-03 | 10 | 118 | 2 | PF13176 | |
| Domain | TYR_PHOSPHATASE_1 | 2.16e-03 | 86 | 118 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 2.25e-03 | 87 | 118 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 2.25e-03 | 87 | 118 | 4 | PS50056 | |
| Domain | Cullin_repeat-like_dom | 2.51e-03 | 12 | 118 | 2 | IPR016159 | |
| Domain | TPR-contain_dom | 2.64e-03 | 150 | 118 | 5 | IPR013026 | |
| Domain | - | 2.76e-03 | 92 | 118 | 4 | 3.90.190.10 | |
| Domain | Myotubularin-like_Pase_dom | 3.43e-03 | 14 | 118 | 2 | IPR010569 | |
| Domain | P_typ_ATPase_c | 3.43e-03 | 14 | 118 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 3.43e-03 | 14 | 118 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 3.43e-03 | 14 | 118 | 2 | IPR006539 | |
| Domain | PPASE_MYOTUBULARIN | 3.43e-03 | 14 | 118 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 3.43e-03 | 14 | 118 | 2 | IPR030564 | |
| Domain | Myotub-related | 3.43e-03 | 14 | 118 | 2 | PF06602 | |
| Domain | PhoLip_ATPase_C | 3.43e-03 | 14 | 118 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 3.43e-03 | 14 | 118 | 2 | PF16209 | |
| Domain | Prot-tyrosine_phosphatase-like | 3.59e-03 | 99 | 118 | 4 | IPR029021 | |
| Domain | TPR_REGION | 3.97e-03 | 165 | 118 | 5 | PS50293 | |
| Domain | TPR | 3.97e-03 | 165 | 118 | 5 | PS50005 | |
| Domain | - | 4.40e-03 | 169 | 118 | 5 | 3.40.50.720 | |
| Domain | CBS | 4.48e-03 | 16 | 118 | 2 | SM00116 | |
| Domain | TPR_8 | 4.58e-03 | 53 | 118 | 3 | PF13181 | |
| Domain | NAD(P)-bd_dom | 4.85e-03 | 173 | 118 | 5 | IPR016040 | |
| Domain | SDR_fam | 5.34e-03 | 56 | 118 | 3 | IPR002347 | |
| Domain | ARM-type_fold | 5.77e-03 | 339 | 118 | 7 | IPR016024 | |
| Domain | PTPc_motif | 6.18e-03 | 59 | 118 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 6.18e-03 | 59 | 118 | 3 | IPR003595 | |
| Pubmed | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.51e-19 | 15 | 120 | 9 | 15640798 | |
| Pubmed | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.21e-18 | 17 | 120 | 9 | 29911975 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.42e-18 | 18 | 120 | 9 | 15570159 |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.42e-18 | 18 | 120 | 9 | 10662547 |
| Pubmed | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.39e-17 | 24 | 120 | 9 | 24698270 | |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.34e-16 | 28 | 120 | 9 | 15347688 |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FCHO2 | 1.12e-13 | 75 | 120 | 10 | 15372022 |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.00e-13 | 57 | 120 | 9 | 32633719 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.72e-13 | 58 | 120 | 9 | 30377227 |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 6.77e-13 | 11 | 120 | 6 | 9655502 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | A2M CPNE9 CLTCL1 PDCD6IP MYO1C MAT2B SERPINF1 YWHAE ABCB1 ABCB4 EEF1G CLTC CST3 FUCA1 RP2 ALDH1A1 CPNE4 RAB21 G6PD TNXB PLSCR1 GOT1 DOP1B | 2.10e-12 | 1070 | 120 | 23 | 23533145 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.12e-12 | 68 | 120 | 9 | 11230163 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.62e-12 | 72 | 120 | 9 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 4.68e-12 | 74 | 120 | 9 | 10817752 |
| Pubmed | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 6.77e-12 | 77 | 120 | 9 | 10835267 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 9.65e-12 | 80 | 120 | 9 | 10716726 |
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 3.49e-10 | 12 | 120 | 5 | 10612399 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.60e-10 | 119 | 120 | 9 | 28625976 |
| Pubmed | PDCD6IP PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.50e-09 | 193 | 120 | 10 | 22589738 | |
| Pubmed | AARS1 GALK1 CLTCL1 PDCD6IP MYO1C MTHFD1L DDX52 DOCK9 ITGB2 YWHAE COG8 EEF1G ATP11B CLTC SCP2 NUP93 KDSR G6PD HSPA14 PLSCR1 | 3.46e-09 | 1168 | 120 | 20 | 19946888 | |
| Pubmed | AARS1 GALK1 PDCD6IP MAT2B RPAP3 MTHFD1L COPG2 BCKDHA YWHAE AARS2 TIAL1 NUP93 CTNND1 FH | 5.17e-09 | 534 | 120 | 14 | 35032548 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | AARS1 GALK1 CLTCL1 AFF2 PDCD6IP MYO1C PCDHA8 COPG2 YWHAE EEF1G CLTC H1-3 DAAM2 ALDH1A1 FH G6PD | 2.01e-08 | 807 | 120 | 16 | 30575818 |
| Pubmed | WDR36 MYO1C MTHFD1L DDX52 COPG2 VPS16 COG8 AARS2 CLTC SMARCC1 NUP93 VPS51 ANAPC7 | 7.76e-08 | 560 | 120 | 13 | 35241646 | |
| Pubmed | AFF2 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA3 PCDHA2 PCDHA1 UHMK1 SMARCC1 | 2.32e-07 | 329 | 120 | 10 | 17474147 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CARM1 A2M AARS1 GALK1 PDCD6IP MTHFD1L OBSL1 YWHAE CDC14A MTMR4 PTPRM MTMR3 NUP93 ESPL1 G6PD ARMC8 | 2.59e-07 | 974 | 120 | 16 | 28675297 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GALK1 PDCD6IP MYO1C SERPINF1 YWHAE ABCB1 CLTC CST3 FUCA1 RP2 ALDH1A1 RAB21 G6PD PLSCR1 GOT1 DOP1B | 4.54e-07 | 1016 | 120 | 16 | 19056867 |
| Pubmed | AARS1 PDCD6IP MTHFD1L COPG2 PCDHA4 H1-3 OSBPL11 SMARCC1 NUP93 G6PD GOT1 | 5.05e-07 | 451 | 120 | 11 | 36168627 | |
| Pubmed | AARS1 GALK1 PDCD6IP MYO1C MTHFD1L COPG2 YWHAE EEF1G CLTC NUP93 FH RAB21 G6PD GOT1 | 7.65e-07 | 803 | 120 | 14 | 36517590 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | A2M AARS1 SPAG1 WDR36 PDCD6IP MYO1C MTHFD1L YWHAE EEF1G AARS2 CLTC CST3 SCP2 SMARCC1 NUP93 NUDCD1 FH G6PD | 1.09e-06 | 1367 | 120 | 18 | 32687490 |
| Pubmed | A2M GALK1 WDR36 DDX52 KNSTRN OBSL1 ALKBH5 DENND1A YWHAE TRMU EEF1G TIAL1 CLTC SMARCC1 NUP93 CTNND1 RAB21 HSPA14 | 1.14e-06 | 1371 | 120 | 18 | 36244648 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SPAG1 GALK1 ATP9B ATP11B PTPRM AGFG1 OSBPL11 ROBO1 CTNND1 VPS51 ANAPC7 HSPA14 CHST3 | 1.30e-06 | 719 | 120 | 13 | 35337019 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | CARM1 A2M AARS1 GALK1 PDCD6IP MTHFD1L AARS2 SCP2 NUP93 CTNND1 FH RAB21 | 1.36e-06 | 607 | 120 | 12 | 39147351 |
| Pubmed | GALK1 CLTCL1 WDR36 PDCD6IP MYO1C MTHFD1L KNSTRN COPG2 BCKDHA FCHO2 DENND1A YWHAE EEF1G AARS2 CLTC NUP93 G6PD ARMC8 | 2.27e-06 | 1440 | 120 | 18 | 30833792 | |
| Pubmed | SPAG1 TTC24 CLTCL1 MYO1C MYH7B DDX52 CC2D1B CHRNA1 ABCB1 ABCB4 TIAL1 CLTC H1-3 SMARCC1 ULK1 ALDH1A1 RAB21 ANAPC7 | 2.32e-06 | 1442 | 120 | 18 | 35575683 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | WDR36 PDCD6IP DDX52 OBSL1 YWHAE ABCB1 EEF1G AARS2 TIAL1 CLTC RP2 NUP93 CTNND1 RAB21 ANAPC7 | 2.60e-06 | 1024 | 120 | 15 | 24711643 |
| Pubmed | AARS1 WDR36 PDCD6IP MYO1C MTHFD1L DDX52 COPG2 CLTC H1-3 SMARCC1 NUP93 FH | 2.89e-06 | 653 | 120 | 12 | 22586326 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 3.26e-06 | 344 | 120 | 9 | 30333137 | |
| Pubmed | MYO1C RPAP3 COPG2 BCKDHA FCHO2 YWHAE CDC14A MTMR4 PTPRM CLTC MTMR3 ROBO1 NUP93 CTNND1 G6PD | 3.48e-06 | 1049 | 120 | 15 | 27880917 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AARS1 GALK1 WDR36 PDCD6IP MYO1C RPAP3 MTHFD1L DDX52 TOR4A VPS16 YWHAE EEF1G CLTC SMARCC1 NUP93 CTNND1 G6PD | 4.18e-06 | 1353 | 120 | 17 | 29467282 |
| Pubmed | Phosphorylated tau interactome in the human Alzheimer's disease brain. | 4.99e-06 | 125 | 120 | 6 | 32812023 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | CARM1 MTHFD1L DDX52 COPG2 VPS16 EEF1G AARS2 TIAL1 CLTC SMARCC1 RAB21 HSPA14 | 6.20e-06 | 704 | 120 | 12 | 29955894 |
| Pubmed | 6.48e-06 | 11 | 120 | 3 | 29604273 | ||
| Pubmed | CPNE9 WDR36 MYO1C MAT2B COPG2 YWHAE EEF1G CLTC H1-3 CPNE4 CTNND1 RAB21 G6PD | 7.43e-06 | 844 | 120 | 13 | 25963833 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | AARS1 WDR36 PDCD6IP MYO1C MAT2B MTHFD1L DDX52 YWHAE EEF1G CLTC SMARCC1 NUP93 CTNND1 FH ANAPC7 G6PD ARMC8 | 8.26e-06 | 1425 | 120 | 17 | 30948266 |
| Pubmed | MAPK8IP1 AARS1 LONRF1 TTLL5 GNPTAB KCNAB2 OBSL1 YWHAE NSMF CLTC MTMR3 ROBO1 DAAM2 PLXNB3 DOP1B ARMC8 | 9.21e-06 | 1285 | 120 | 16 | 35914814 | |
| Pubmed | 1.12e-05 | 144 | 120 | 6 | 35681168 | ||
| Pubmed | AARS1 PDCD6IP MYH7B COPG2 YWHAE EEF1G AARS2 CLTC H1-3 AGFG1 NUP93 FH ANAPC7 | 1.13e-05 | 878 | 120 | 13 | 37223481 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 21549344 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 10488067 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 1.18e-05 | 2 | 120 | 2 | 21705081 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 10552998 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 28441502 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 1.18e-05 | 2 | 120 | 2 | 9196326 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 22184139 | ||
| Pubmed | Isolation and expression of a complementary DNA that confers multidrug resistance. | 1.18e-05 | 2 | 120 | 2 | 3022150 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 2570420 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 8898203 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 2473069 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 28274756 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 19185004 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 18215618 | ||
| Pubmed | Receptor protein-tyrosine phosphatase RPTPmu binds to and dephosphorylates the catenin p120(ctn). | 1.18e-05 | 2 | 120 | 2 | 10753936 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 21998202 | ||
| Pubmed | ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD. | 1.18e-05 | 2 | 120 | 2 | 34297301 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 19948828 | ||
| Pubmed | What have we learnt thus far from mice with disrupted P-glycoprotein genes? | 1.18e-05 | 2 | 120 | 2 | 8763339 | |
| Pubmed | Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. | 1.18e-05 | 2 | 120 | 2 | 9473291 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 2471060 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 8733129 | ||
| Pubmed | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 1.18e-05 | 2 | 120 | 2 | 18231753 | |
| Pubmed | ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. | 1.18e-05 | 2 | 120 | 2 | 32058310 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 29097553 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 3768958 | ||
| Pubmed | Intron-less processed Pcdhalpha genes in the central nervous system. | 1.18e-05 | 2 | 120 | 2 | 14697259 | |
| Pubmed | The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step. | 1.18e-05 | 2 | 120 | 2 | 20065094 | |
| Pubmed | Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice. | 1.18e-05 | 2 | 120 | 2 | 38522903 | |
| Pubmed | Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. | 1.18e-05 | 2 | 120 | 2 | 3477522 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 16857572 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 1969609 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 24140176 | ||
| Pubmed | Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. | 1.18e-05 | 2 | 120 | 2 | 9419367 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 2248681 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 17440929 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 7832992 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 11826402 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 10453001 | ||
| Pubmed | 1.52e-05 | 417 | 120 | 9 | 19199708 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | WDR36 MYO1C RPAP3 MTHFD1L TTLL5 OBSL1 BCKDHA YWHAE AARS2 TOX3 CLTC H1-3 MTMR3 OSBPL11 SCP2 ESPL1 ANAPC7 | 1.55e-05 | 1496 | 120 | 17 | 32877691 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | A2M AARS1 GALK1 CLTCL1 MYO1C MYH7B COPG2 TOR4A YWHAE AARS2 CLTC | 1.58e-05 | 647 | 120 | 11 | 26618866 |
| Pubmed | 1.77e-05 | 15 | 120 | 3 | 20468060 | ||
| Pubmed | 2.17e-05 | 16 | 120 | 3 | 19794400 | ||
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 2.17e-05 | 16 | 120 | 3 | 21738476 | |
| Pubmed | 2.24e-05 | 551 | 120 | 10 | 34728620 | ||
| Pubmed | 2.60e-05 | 167 | 120 | 6 | 25659891 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 2.71e-05 | 344 | 120 | 8 | 36282215 | |
| Pubmed | 2.78e-05 | 565 | 120 | 10 | 20458337 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 2.95e-05 | 569 | 120 | 10 | 30639242 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | ALKBH5 P3H4 PLIN2 EEF1G AGFG1 SCP2 FUCA1 CTNND1 FH ANAPC7 HSPA14 | 3.41e-05 | 704 | 120 | 11 | 32994395 |
| Pubmed | Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. | 3.53e-05 | 3 | 120 | 2 | 7814632 | |
| Pubmed | Functional equivalence of the clathrin heavy chains CHC17 and CHC22 in endocytosis and mitosis. | 3.53e-05 | 3 | 120 | 2 | 19509056 | |
| Interaction | PCDHA10 interactions | 3.47e-13 | 22 | 119 | 8 | int:PCDHA10 | |
| Interaction | PCDHA8 interactions | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 3.25e-11 | 55 | 119 | 9 | int:PCDHA8 |
| Interaction | FLT3 interactions | MTHFD1L DDX52 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 NUP93 VPS51 DOP1B | 5.95e-09 | 318 | 119 | 14 | int:FLT3 |
| Interaction | PCDHA7 interactions | 1.27e-08 | 14 | 119 | 5 | int:PCDHA7 | |
| Interaction | PCDHA1 interactions | 1.42e-07 | 9 | 119 | 4 | int:PCDHA1 | |
| Interaction | PCDHA11 interactions | 4.18e-06 | 19 | 119 | 4 | int:PCDHA11 | |
| Interaction | PCDHA6 interactions | 1.64e-05 | 9 | 119 | 3 | int:PCDHA6 | |
| Interaction | CUTA interactions | 1.98e-05 | 56 | 119 | 5 | int:CUTA | |
| Interaction | PCDHA4 interactions | 2.78e-05 | 60 | 119 | 5 | int:PCDHA4 | |
| Interaction | MTMR7 interactions | 3.81e-05 | 64 | 119 | 5 | int:MTMR7 | |
| Interaction | GTSE1 interactions | 4.19e-05 | 215 | 119 | 8 | int:GTSE1 | |
| Interaction | PCDHA3 interactions | 4.67e-05 | 34 | 119 | 4 | int:PCDHA3 | |
| Interaction | PCDHA2 interactions | 6.97e-05 | 14 | 119 | 3 | int:PCDHA2 | |
| Interaction | C9orf78 interactions | WDR36 MYO1C MTHFD1L DDX52 COPG2 VPS16 COG8 AARS2 CLTC SMARCC1 NUP93 VPS51 ANAPC7 | 7.69e-05 | 620 | 119 | 13 | int:C9orf78 |
| Interaction | STAMBPL1 interactions | 8.19e-05 | 75 | 119 | 5 | int:STAMBPL1 | |
| Interaction | RAB11A interactions | CARM1 ABCB1 MTMR4 ATP11B TOX3 CLTC AGFG1 OSBPL11 ROBO1 NUP93 CTNND1 VPS51 RAB21 G6PD DOP1B | 1.12e-04 | 830 | 119 | 15 | int:RAB11A |
| Interaction | AGR2 interactions | AARS1 GALK1 CLTCL1 AFF2 PDCD6IP MYO1C PCDHA8 COPG2 YWHAE EEF1G CLTC H1-3 DAAM2 ALDH1A1 FH G6PD | 1.22e-04 | 934 | 119 | 16 | int:AGR2 |
| Cytoband | 5q31 | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.34e-11 | 115 | 120 | 9 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 SLC35A4 | 7.07e-09 | 298 | 120 | 10 | chr5q31 |
| GeneFamily | Clustered protocadherins | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 2.01e-11 | 64 | 87 | 9 | 20 |
| GeneFamily | Copines | 8.06e-04 | 9 | 87 | 2 | 829 | |
| GeneFamily | Chloride voltage-gated channels | 1.00e-03 | 10 | 87 | 2 | 302 | |
| GeneFamily | ATP binding cassette subfamily B | 1.22e-03 | 11 | 87 | 2 | 806 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.30e-03 | 115 | 87 | 4 | 769 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 2.31e-03 | 15 | 87 | 2 | 903 | |
| GeneFamily | ATPase phospholipid transporting | 2.31e-03 | 15 | 87 | 2 | 1210 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 3.71e-03 | 19 | 87 | 2 | 132 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FSCN2 | 3.31e-07 | 261 | 119 | 10 | MM1277 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED | PCDHA13 PCDHA12 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 FSCN2 | 1.47e-06 | 238 | 119 | 9 | M2020 |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 3.66e-06 | 199 | 119 | 8 | M9420 | |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN | 3.80e-06 | 200 | 119 | 8 | M6249 | |
| Coexpression | GSE3982_MAST_CELL_VS_BASOPHIL_UP | 3.35e-05 | 197 | 119 | 7 | M5438 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN | 3.69e-05 | 200 | 119 | 7 | M5303 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN | 6.01e-05 | 148 | 119 | 6 | M40921 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | A2M SPAG1 PDCD6IP MYO1C MAT2B DDX52 GNPTAB ITGB2 ABCB1 ATP11B PTPRM SMARCC1 FUCA1 FH KDSR PLSCR1 GOT1 | 6.46e-05 | 1276 | 119 | 17 | M39173 |
| Coexpression | HALLMARK_PEROXISOME | 1.14e-04 | 104 | 119 | 5 | M5949 | |
| Coexpression | GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN | 1.71e-04 | 179 | 119 | 6 | M8928 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP | 2.29e-04 | 189 | 119 | 6 | M9978 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | AARS1 MAT2B LONRF1 KNSTRN ALKBH5 YWHAE MTMR4 SMARCC1 DAAM2 NUDCD1 FH KDSR ESPL1 TOX2 PLSCR1 GOT1 | 2.44e-04 | 1290 | 119 | 16 | M80 |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 2.48e-04 | 67 | 119 | 4 | M1686 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN | 2.57e-04 | 193 | 119 | 6 | M8288 | |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP | 2.61e-04 | 461 | 119 | 9 | M14127 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 3.03e-04 | 199 | 119 | 6 | M9418 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN | 3.03e-04 | 199 | 119 | 6 | M7924 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN | 3.03e-04 | 199 | 119 | 6 | M4331 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM | 3.10e-04 | 71 | 119 | 4 | MM1210 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 3.11e-04 | 200 | 119 | 6 | M9496 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_BMDM_DN | 3.11e-04 | 200 | 119 | 6 | M5814 | |
| Coexpression | GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP | 3.11e-04 | 200 | 119 | 6 | M8959 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN | 3.11e-04 | 200 | 119 | 6 | M4527 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP | 3.11e-04 | 200 | 119 | 6 | M3236 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN | 3.11e-04 | 200 | 119 | 6 | M5296 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 3.11e-04 | 200 | 119 | 6 | M6653 | |
| Coexpression | GSE27786_NKTCELL_VS_NEUTROPHIL_DN | 3.11e-04 | 200 | 119 | 6 | M4869 | |
| Coexpression | GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP | 3.11e-04 | 200 | 119 | 6 | M9899 | |
| Coexpression | GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP | 3.11e-04 | 200 | 119 | 6 | M7234 | |
| Coexpression | GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP | 3.11e-04 | 200 | 119 | 6 | M8614 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP | 3.11e-04 | 200 | 119 | 6 | M8610 | |
| Coexpression | GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN | 3.11e-04 | 200 | 119 | 6 | M9081 | |
| Coexpression | GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN | 3.11e-04 | 200 | 119 | 6 | M7177 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP | 3.11e-04 | 200 | 119 | 6 | M4966 | |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 3.11e-04 | 200 | 119 | 6 | M7168 | |
| Coexpression | GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP | 3.11e-04 | 200 | 119 | 6 | M8482 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN | 3.11e-04 | 200 | 119 | 6 | M9842 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TREG_DN | 3.11e-04 | 200 | 119 | 6 | M5744 | |
| Coexpression | GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN | 3.11e-04 | 200 | 119 | 6 | M3059 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP | 3.11e-04 | 200 | 119 | 6 | M4313 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 5.93e-07 | 180 | 120 | 7 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_C|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-06 | 68 | 120 | 5 | 1f432e77d83bf6900c29c5c07fefc8662440490b | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.64e-06 | 159 | 120 | 6 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 188 | 120 | 6 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-05 | 192 | 120 | 6 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-05 | 192 | 120 | 6 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 193 | 120 | 6 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 193 | 120 | 6 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-05 | 193 | 120 | 6 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 1.40e-05 | 193 | 120 | 6 | c97f9b13057f803df63c696c6175ef8e0aba6fa7 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 194 | 120 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 194 | 120 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.49e-05 | 195 | 120 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 1.58e-05 | 197 | 120 | 6 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_Resident_macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.62e-05 | 198 | 120 | 6 | 30bf78d4d657cf5140549d3dbf43d4f00482e300 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | background-Hepatocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.72e-05 | 200 | 120 | 6 | 787d35b5c2f2ad967ae14e99496a0299ac7e72fd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.72e-05 | 200 | 120 | 6 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.30e-05 | 155 | 120 | 5 | 8dab23aad905cc35a35643baa0554acb3f6fe6c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.30e-05 | 155 | 120 | 5 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.30e-05 | 155 | 120 | 5 | 42533beaded07068f00540de704de07e4f19abcf | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.25e-05 | 85 | 120 | 4 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.25e-05 | 85 | 120 | 4 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.71e-05 | 166 | 120 | 5 | 9f14e3ef19d5903278c040be1c477501237173fa | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.74e-05 | 170 | 120 | 5 | d72eb77271d61e27a3d247149561c7f45fadb28b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 172 | 120 | 5 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | BAL-Control-cDC_11|Control / Compartment, Disease Groups and Clusters | 1.12e-04 | 175 | 120 | 5 | daf014e15a354956e9149c83fd89d0af0d07eb00 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.18e-04 | 177 | 120 | 5 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-04 | 177 | 120 | 5 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 1.18e-04 | 177 | 120 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-cDC1|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 181 | 120 | 5 | 84ca8c9c036478a6d3a2071919d09065455d417c | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.41e-04 | 184 | 120 | 5 | 667846c422cfa27e949a24844a305df859cb6760 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-04 | 184 | 120 | 5 | a6f8b42982ec0cf44b950a2cd9715d068eec4ecb | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-04 | 185 | 120 | 5 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.45e-04 | 185 | 120 | 5 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-04 | 185 | 120 | 5 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.45e-04 | 185 | 120 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.45e-04 | 185 | 120 | 5 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.45e-04 | 185 | 120 | 5 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.45e-04 | 185 | 120 | 5 | 0e8064bb317f26959d3c59b4f73d0c455161ccd7 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.45e-04 | 185 | 120 | 5 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.45e-04 | 185 | 120 | 5 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.48e-04 | 186 | 120 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 186 | 120 | 5 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.52e-04 | 187 | 120 | 5 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-04 | 187 | 120 | 5 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-04 | 187 | 120 | 5 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.52e-04 | 187 | 120 | 5 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.56e-04 | 188 | 120 | 5 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.56e-04 | 188 | 120 | 5 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-04 | 188 | 120 | 5 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-04 | 190 | 120 | 5 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.64e-04 | 190 | 120 | 5 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.64e-04 | 190 | 120 | 5 | 07215e8f292cb54c670037aaf28393cddbe5548c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 190 | 120 | 5 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 190 | 120 | 5 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.68e-04 | 191 | 120 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.68e-04 | 191 | 120 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-04 | 192 | 120 | 5 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.72e-04 | 192 | 120 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-04 | 192 | 120 | 5 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 193 | 120 | 5 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 1.76e-04 | 193 | 120 | 5 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 193 | 120 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 193 | 120 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-04 | 193 | 120 | 5 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.76e-04 | 193 | 120 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 1.81e-04 | 194 | 120 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-04 | 194 | 120 | 5 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 194 | 120 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 194 | 120 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 194 | 120 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.81e-04 | 194 | 120 | 5 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.85e-04 | 195 | 120 | 5 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.85e-04 | 195 | 120 | 5 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.85e-04 | 195 | 120 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | CV-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 1.89e-04 | 196 | 120 | 5 | f121b009d64704177f73f2da3848f0ad6ed6bf1f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-04 | 196 | 120 | 5 | efdc95811e8b17243065ae82d748ea2c5775fdbc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-04 | 196 | 120 | 5 | 3392efa5007736b1e87f34805c16e8baa792e596 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo|GI_small-bowel / Manually curated celltypes from each tissue | 1.89e-04 | 196 | 120 | 5 | a54ec174461944229c98a0b48b4822a556191ccb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-04 | 196 | 120 | 5 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd|GI_small-bowel / Manually curated celltypes from each tissue | 1.89e-04 | 196 | 120 | 5 | 84cab9390794fe50203834b745722bf11c208ebd | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_Resident_macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.94e-04 | 197 | 120 | 5 | 8736f1d446db3eb28a99997a9a683ded8e18e4c6 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.94e-04 | 197 | 120 | 5 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-04 | 197 | 120 | 5 | e2983ae16c72371fbf0e5c123de9f4d900724e5e | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Erythrophagocytic_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 1.94e-04 | 197 | 120 | 5 | be9879e3352b8c17e91ab1e2d1fb4c30ef6d8ce8 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.94e-04 | 197 | 120 | 5 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 1.94e-04 | 197 | 120 | 5 | d8dc65b580191827ab6bbad5e29f0089419ebaef | |
| ToppCell | Healthy/Control-cDC|World / Disease group and Cell class | 1.94e-04 | 197 | 120 | 5 | 4497d4073f4d3e74de907325fba9eb4af5766bf4 | |
| ToppCell | mild_COVID-19-cDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.94e-04 | 197 | 120 | 5 | 44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-04 | 198 | 120 | 5 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-04 | 198 | 120 | 5 | 8a4b4bb6839b9ec52ff0b9c7b39cec8d9a9525bd | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_only / Treatment groups by lineage, cell group, cell type | 1.99e-04 | 198 | 120 | 5 | d205dfcfe1f20e1e21bf84759e723d9e6e610a5c | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_macrophage|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-04 | 198 | 120 | 5 | c08018f099a381a66993cb60288954a6e47f105f | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.99e-04 | 198 | 120 | 5 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-04 | 198 | 120 | 5 | 27cc7f786fb8cb230589d762a4e51b46265c1f19 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-04 | 199 | 120 | 5 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 199 | 120 | 5 | 63e632b06e13d2bcde5a00a51962bafdf60fd6c6 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.03e-04 | 199 | 120 | 5 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| Drug | C12-NBD-PC | 2.45e-08 | 7 | 119 | 4 | CID006439314 | |
| Drug | Azacitidine | PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 BCL2L1 ITGB2 UHMK1 CST3 ASB2 | 2.76e-07 | 415 | 119 | 13 | ctd:D001374 |
| Drug | AC1N9ZZC | 1.36e-05 | 149 | 119 | 7 | CID004369374 | |
| Drug | Methapyrilene | A2M KNSTRN BCKDHA ABCB1 ABCB4 EEF1G UHMK1 ALDH1A1 CPNE4 G6PD | 1.45e-05 | 347 | 119 | 10 | ctd:D008701 |
| Drug | cc-637 | 1.63e-05 | 10 | 119 | 3 | CID000002350 | |
| Drug | bupranolol | 1.98e-05 | 63 | 119 | 5 | CID000002475 | |
| Drug | Badg | 2.71e-05 | 2 | 119 | 2 | CID000125951 | |
| Drug | 1,9-dideoxyforskolin | 2.71e-05 | 2 | 119 | 2 | ctd:C047983 | |
| Drug | S-methyl N,N-diethylthiolcarbamate sulfoxide | 2.71e-05 | 2 | 119 | 2 | ctd:C073220 | |
| Drug | 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid | 2.71e-05 | 2 | 119 | 2 | ctd:C059164 | |
| Drug | 5-hydroxy-6,8,11,14,17-eicosapentaenoic acid | 2.96e-05 | 12 | 119 | 3 | ctd:C058722 | |
| Drug | IC-1 | 2.96e-05 | 12 | 119 | 3 | CID000049829 | |
| Drug | DB02197 | 3.67e-05 | 36 | 119 | 4 | CID005288527 | |
| Disease | 1,5 anhydroglucitol measurement | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 1.79e-15 | 29 | 118 | 9 | EFO_0008009 |
| Disease | visceral adipose tissue measurement, body mass index | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 | 7.58e-11 | 87 | 118 | 9 | EFO_0004340, EFO_0004765 |
| Disease | neutrophil count, basophil count | PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 YWHAE TGS1 | 1.77e-09 | 224 | 118 | 11 | EFO_0004833, EFO_0005090 |
| Disease | post-traumatic stress disorder symptom measurement | 4.05e-08 | 82 | 118 | 7 | EFO_0008535 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.43e-06 | 24 | 118 | 4 | DOID:10595 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | AMH MYO1C WNT2B PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 COLEC10 CCDC141 P3H4 PLIN2 CLCN6 CTNND1 BRD1 | 2.69e-06 | 1392 | 118 | 19 | EFO_0005763 |
| Disease | neuroticism measurement, cognitive function measurement | KCNAB2 PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 DENND1A YWHAE | 2.98e-06 | 566 | 118 | 12 | EFO_0007660, EFO_0008354 |
| Disease | cystic fibrosis (implicated_via_orthology) | 5.15e-06 | 9 | 118 | 3 | DOID:1485 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | A2M MYO1C TOR4A ITGB2 PLIN2 ABCB1 NSMF TIAL1 AGFG1 SMARCC1 ALDH1A1 PLSCR1 GOT1 | 1.40e-05 | 774 | 118 | 13 | C0023893 |
| Disease | dermatomyositis (implicated_via_orthology) | 1.59e-05 | 2 | 118 | 2 | DOID:10223 (implicated_via_orthology) | |
| Disease | axonal neuropathy (implicated_via_orthology) | 1.59e-05 | 2 | 118 | 2 | DOID:7319 (implicated_via_orthology) | |
| Disease | hemolytic anemia (implicated_via_orthology) | 1.59e-05 | 2 | 118 | 2 | DOID:583 (implicated_via_orthology) | |
| Disease | Abnormality of refraction | MTHFD1L PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 MTMR3 ROBO1 | 1.70e-05 | 673 | 118 | 12 | HP_0000539 |
| Disease | post-traumatic stress disorder | 1.76e-05 | 202 | 118 | 7 | EFO_0001358 | |
| Disease | neutrophil count | MYO1C PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 YWHAE CDC14A UHMK1 CPNE4 TOX2 TNXB TGS1 | 3.61e-05 | 1382 | 118 | 17 | EFO_0004833 |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 7.54e-05 | 108 | 118 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | liver disease (implicated_via_orthology) | 9.46e-05 | 4 | 118 | 2 | DOID:409 (implicated_via_orthology) | |
| Disease | vital capacity | MYO1C MYH7B WNT2B PCDHA13 PCDHA12 PCDHA8 PCDHA7 PCDHA6 PCDHA4 PCDHA3 PCDHA2 PCDHA1 BCL2L1 MTMR3 TNXB | 1.25e-04 | 1236 | 118 | 15 | EFO_0004312 |
| Disease | hepatocellular adenoma (biomarker_via_orthology) | 1.57e-04 | 5 | 118 | 2 | DOID:0050868 (biomarker_via_orthology) | |
| Disease | depressive symptom measurement | 3.24e-04 | 426 | 118 | 8 | EFO_0007006 | |
| Disease | nephroblastoma (is_marker_for) | 3.41e-04 | 34 | 118 | 3 | DOID:2154 (is_marker_for) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 4.37e-04 | 8 | 118 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 4.37e-04 | 8 | 118 | 2 | EFO_0801768 | |
| Disease | emotional symptom measurement | 5.60e-04 | 9 | 118 | 2 | EFO_0007803 | |
| Disease | gallbladder neoplasm | 5.60e-04 | 9 | 118 | 2 | EFO_0004606 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 5.60e-04 | 9 | 118 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | retinitis pigmentosa (is_implicated_in) | 5.95e-04 | 41 | 118 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 7.83e-04 | 45 | 118 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | transient cerebral ischemia (is_implicated_in) | 8.52e-04 | 11 | 118 | 2 | DOID:224 (is_implicated_in) | |
| Disease | cholestasis (biomarker_via_orthology) | 1.00e-03 | 49 | 118 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 1.41e-03 | 55 | 118 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.61e-03 | 15 | 118 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Intrahepatic cholestasis of pregnancy | 1.83e-03 | 16 | 118 | 2 | EFO_0009048 | |
| Disease | ulcerative colitis (is_implicated_in) | 2.07e-03 | 17 | 118 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 2.21e-03 | 136 | 118 | 4 | DOID:9352 (is_marker_for) | |
| Disease | Disorder of organic acid metabolism | 2.33e-03 | 18 | 118 | 2 | cv:C1263739 | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 3.04e-03 | 72 | 118 | 3 | DOID:9744 (is_marker_for) | |
| Disease | chronic myeloid leukemia (is_implicated_in) | 3.17e-03 | 21 | 118 | 2 | DOID:8552 (is_implicated_in) | |
| Disease | wellbeing measurement, alcohol consumption measurement | 3.29e-03 | 74 | 118 | 3 | EFO_0007869, EFO_0007878 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLAEFATGNDRKEAA | 131 | P62258 | |
| FSADAARFQIGKRKY | 21 | Q9Y2R4 | |
| IENGNYAKAARIAAE | 896 | O95696 | |
| YAKAARIAAEVGQSS | 901 | O95696 | |
| KRANAAFLIGAYAVI | 91 | Q9UNH5 | |
| ALRFLAKYGADINTQ | 286 | Q96Q27 | |
| DNYKAGSREAAAAAA | 21 | Q6P6C2 | |
| EKFGKAVNYADAALS | 1091 | P51816 | |
| AVALTESVNAYFKGA | 546 | Q0JRZ9 | |
| FVELYGNNAAAESRK | 191 | Q07817 | |
| DVIKRANNTFYGLSA | 416 | P00352 | |
| ANTLIADYVAKSGFF | 191 | Q9Y6Z7 | |
| KGHYRQAQFDIAVAS | 596 | Q6UB35 | |
| TKALLAYAFALAGNQ | 1146 | P01023 | |
| AYAFALAGNQDKRKE | 1151 | P01023 | |
| AERYRAQGISANKFV | 671 | Q8N1F7 | |
| AAAAGRAYSFKVVLL | 11 | Q9UL25 | |
| LKLEDFFARNSYVAG | 96 | P11413 | |
| ATFNALGYVQASKRD | 481 | Q96RS6 | |
| VAKVRAVDADSGYNA | 591 | Q9Y5H9 | |
| VAKVRAVDADSGYNA | 591 | Q9UN73 | |
| SIEAFANARGAAYEI | 351 | P08183 | |
| ANARGAAYEIFKIID | 356 | P08183 | |
| VLYNNADGDFAIVKF | 111 | P02708 | |
| IKAYAFVHTGDNSRA | 206 | Q9UJX3 | |
| ARNAAGEAYAAAAVT | 86 | O75147 | |
| VAKVRAVDADSGYNA | 591 | Q9UN72 | |
| GAYGFRVASLNKIAD | 816 | Q86T65 | |
| VAKVRAVDADSGYNA | 591 | Q9Y5H6 | |
| VAKVRAVDADSGYNA | 591 | Q9Y5H8 | |
| AKEAAAVGAFLIYIS | 121 | Q9NZL9 | |
| AAAFYKNILGAQVSE | 61 | Q96PE7 | |
| VLFDSYRDNIAGKSF | 51 | Q3T906 | |
| RALATGQFAVFYKGD | 361 | O75648 | |
| KALAESVGRAFQQFY | 681 | Q9UQF2 | |
| RAESYAGLQEFKAAI | 251 | Q17RB8 | |
| AAANRKRAAYYSAAG | 16 | O43861 | |
| KRQAFAVFSGELDQY | 2031 | Q9Y3R5 | |
| SKQGAADYSRFVRDA | 406 | Q9UBK8 | |
| FAAQAGARKIYAVEA | 201 | Q86X55 | |
| VFAVGALAKATYDRL | 466 | A7E2Y1 | |
| AIIAKLANQAADYFG | 211 | Q8WUM4 | |
| IKNSFGQRVYFAAED | 131 | O15162 | |
| GAKAALVEFAEYLNR | 61 | A0A0J9YXQ4 | |
| GRAFADVQYAVSVAS | 861 | Q9ULL4 | |
| QFASIDVAGNLDYKA | 146 | Q02045 | |
| ADLFQAAGAKYVVLT | 121 | P04066 | |
| ATFYLSQAADGAKVL | 376 | P51570 | |
| DLAFANYKTFIRGAE | 81 | Q96MW5 | |
| AKVRAARAFGEYLSQ | 21 | Q6X4W1 | |
| LSAYEQAFLGAVQRA | 76 | P03971 | |
| INLFDTAEVYAAGKA | 81 | Q13303 | |
| ARSYTAAVANRAKGG | 311 | Q9NYA4 | |
| LQGVIFNDVYAASKF | 146 | Q9NYR8 | |
| AFANARGAAYVIFDI | 356 | P21439 | |
| VAKVRAVDADSGYNA | 591 | Q9Y5I3 | |
| VAKVRAVDADSGYNA | 591 | Q9Y5I0 | |
| YVFKNALRLGTFSAV | 316 | Q9H237 | |
| VAKVRAVDADSGYNA | 591 | Q9UN74 | |
| QAAAFNVTFRRAKGY | 111 | P05107 | |
| ELRQAAFKLYASLGA | 356 | Q8IUR7 | |
| GAAFGRLVANVLKSY | 496 | P51797 | |
| AYKAVRADTGQERFN | 591 | Q14674 | |
| SANKAFDVLGRVEAY | 361 | Q6ZP82 | |
| ASGNLDKNARFSAIY | 536 | Q9BZ29 | |
| FGILKRAAAEVNQDY | 96 | P07954 | |
| SGNDDYVELAFNARK | 151 | Q96A23 | |
| KTFYQAFTEAAARGE | 321 | P51841 | |
| QVARAAAKISDGSQY | 411 | Q8IYJ1 | |
| NYREAAASAKEAGEA | 176 | Q5T0F9 | |
| AVFSAAGFKDIRSYR | 146 | P17174 | |
| AVRAAAVSALAKFGA | 486 | Q9UBF2 | |
| QAAFFGSYRNALKIE | 316 | Q8TEH3 | |
| FKALIAAQYSGAQVR | 16 | P26641 | |
| AYSKLGFADLNLAEF | 96 | Q5T9C2 | |
| ALAAAGYDVEKNNSR | 66 | P16402 | |
| KALAVDAAFREGNAA | 261 | A6NKF1 | |
| YSASKFAIRGLAEAL | 186 | Q06136 | |
| RALDFAVGEYNKASN | 51 | P01034 | |
| GFRLDAVKSNAAAYL | 376 | O60716 | |
| DARSYAAAVANRAKG | 316 | Q13615 | |
| AVGAAYAAKRANANR | 216 | P12694 | |
| YFQAASRANGETKID | 701 | P28827 | |
| VAKVRAVDADSGYNA | 591 | Q9UN75 | |
| NAASGEQYKLRATDA | 126 | Q9BXB4 | |
| ARIYAAGFDSSKNIF | 151 | Q96FA3 | |
| AVYKDGRAGVVANDA | 16 | Q0VDF9 | |
| DRYLTAESFGFKVNA | 21 | O14926 | |
| YRKFLFETQAADLAG | 31 | Q9Y448 | |
| KYALAAGQFRTALEL | 191 | Q9BXB7 | |
| AAAAILASEAFVQKY | 231 | P22307 | |
| IAAAAAGLAVYRRKD | 21 | Q92922 | |
| AAKASAVRAAFLNFF | 36 | Q5JTZ9 | |
| KYAALANLDNIFSAG | 326 | P52594 | |
| LFAQGNYSEAAKVAA | 371 | Q00610 | |
| RKFNTLFAQGSYAEA | 366 | P53675 | |
| LFAQGSYAEAAKVAA | 371 | P53675 | |
| FGYKLARDAAALTNR | 451 | Q7LGC8 | |
| YTQDLGAFAKEEAAR | 26 | P51788 | |
| KEGRQAARNSDYAIA | 841 | Q9Y2G3 | |
| FLAGYVVAKLRASAV | 51 | L0R6Q1 | |
| KLAAFARQLGSRYFA | 336 | Q9UID3 | |
| AAAARLGQYDQALKY | 361 | A2A3L6 | |
| AARGLAFALFASVYK | 311 | Q5GH72 | |
| VNKLAAAVSNFGYDL | 51 | P36955 | |
| AVRYAHEKLNASRGF | 331 | P49588 | |
| QAILLDGSYSKAFAR | 341 | Q9H6T3 | |
| AVFLRAVKLYNSGDF | 206 | Q92791 | |
| FAEAAGKYSAAIALL | 461 | Q07617 | |
| LADGNVKAFYRRALA | 686 | Q07617 | |
| GRVAALQTAADAFYK | 646 | Q9H269 | |
| SRADSFKVSYQLADG | 3781 | P22105 | |
| FAGDYTIANARKLID | 241 | O75695 | |
| AVAAAAEYAGLKVAR | 1406 | Q9Y6N7 | |
| AYALFFRDTQAAIKG | 261 | O15405 | |
| AENLAAQLSFYRVAG | 391 | Q9NXH8 | |
| AYALFFRDTQAAIKG | 261 | Q96NM4 | |
| GDIYSVFRNAASFKE | 351 | Q99541 | |
| ALARNNAEVYGIADK | 726 | Q96RS0 | |
| GFVSFYNKLDAENAI | 141 | Q01085 | |
| ASAAEYGFRKERAAL | 66 | Q8TAS1 | |
| VKIADFGFARYLQSN | 161 | O75385 | |
| ARFATVRYDQGAKNI | 246 | Q6EMB2 | |
| NIHYGVRFAKAFVDA | 191 | Q93097 | |
| YGNVFSAFARNKEIV | 141 | Q8NI36 | |
| LEQAAYARDALAKAV | 371 | O00159 |